Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

Stock Information for GlucoTrack Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About GlucoTrack Inc.

Glucotrack to Present at LSI USA '26 Medtech Innovation Summit
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights
Glucotrack, Inc. Encourages Shareholders to Vote
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
Glucotrack, Inc. Reminds Shareholders to Vote
Glucotrack to Participate in the Q3 Virtual Investor Summit
Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.